↓ Skip to main content

Dove Medical Press

Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, November 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
19 Mendeley
Title
Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
Published in
ClinicoEconomics and Outcomes Research: CEOR, November 2019
DOI 10.2147/ceor.s226323
Pubmed ID
Authors

Gabriel Tremblay, Qayyim Said, Anuja Nidumolu Roy, Beilei Cai, Shan Ashton Garib, Jaclyn Hearnden, Anna Forsythe

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 21%
Student > Ph. D. Student 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 5%
Other 1 5%
Other 3 16%
Unknown 6 32%
Readers by discipline Count As %
Business, Management and Accounting 5 26%
Medicine and Dentistry 3 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Nursing and Health Professions 1 5%
Immunology and Microbiology 1 5%
Other 1 5%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2023.
All research outputs
#8,572,011
of 25,462,162 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#202
of 525 outputs
Outputs of similar age
#149,863
of 378,384 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#4
of 10 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,384 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.